Categories AlphaGraphs, Earnings, Technology
Infographic: Highlights of Roku’s Q2 2022 earnings report
Roku’s stock (NASDAQ: ROKU) suffered a big fall this week after the streaming platform reported a net loss for the second quarter of 2022, compared to a profit last year, hurt by continued weakness in ad spending.
The company reported total revenues of $764.4 million for the three-month period, which is up 18% from the year-ago period. The number of active users increased 14% to 63.1 million. At $44.10, the average revenue per user was up 21%.
Roku reported a net loss of $112.3 million or $0.82 per share for the June quarter, which marked a deterioration from the prior-year period when the company reported a net profit of $73.5 million or $0.52 per share.
Check this space to read management/analysts’ comments on Roku’s Q2 2022 earnings
“We are in an economic environment defined by recessionary fears, inflationary pressures, rising interest rates, and ongoing supply chain disruptions. For the second half of the year, we are forecasting that advertising spend, particularly in the scatter market, will continue to be negatively impacted. We also believe that consumer discretionary spend will continue to moderate, pressuring both Roku TV and Roku player sales,” said Anthony Wood, CEO of Roku.
Prior Performance
_________________________________________________________________________________________________________________
Stocks you may like:
International Business Machines Corp. (IBM) Stock
_________________________________________________________________________________________________________________
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company